AC and DC magnetic softness enhanced dual-doped γ-Fe2O3 nanoparticles for highly efficient cancer theranostics AITranslate

Basic Information:

DOI：https://doi.org/10.1016/j.apmt.2022.101533

Chinese Library Classification Number:

Citation Information:

ABSTRACT “Theranostics” by magnetic nanofluid hyperthermia (MNFH) combined with T2-weighted MR contrast imaging (MRI) using superparamagnetic nanoparticles (SPNPs) has been drawn a huge attraction in nanomedicine. However, insufficient AC heating power at the biologically safe range of AC magnetic field (HAC) (Happl < 190 Oe, fappl < 120 kHz) and unsatisfactorily low r2-relaxivity keep SPNPs challenging for cancer theranostics agent applications. Here, innovatively designed and developed AC and DC magnetic softness enhanced dual-doped (Ni0.6Zn0.4)-γFe2O3 (MSEγ-IO) SPNPs with significantly enhanced both intrinsic loss power (ILP, ∼ 4.0 nH m2 kg−1) at the Happl⋅fappl = 1.23×109 A m−1 s−1 and r2-relaxivity (r2 = 660.4 mM−1 s−1) are reported. The significantly enhanced ILP, and r2-relaxivity of dual-doped MSEγ-IO SPNPs were primarily attributed to the distinctly enhanced AC magnetic softness directly related to the HAC absorption and fappl resonance efficiency, and the DC magnetic softness dominantly controlled by the occupation and spatial distribution of Ni2+ in Oh vacancies sites, and Zn2+ cations in Td sites of γ-Fe2O3, respectively. The biocompatibility and bioavailability experimentally evaluated by in-vitro and in-vivo studies demonstrated that the dual-doped MSEγ-IO SPNPs can be a promising candidate for highly efficient cancer theranostics agent for future nanomedicine. Graphical abstract Download : Download high-res image (197KB) Download : Download full-size image